Anatomical compartments (e.g., the reproductive tract) are reservoirs of human immunodeficiency virus type-1 (HIV-1) and potential sites of residual infection in patients receiving anti-retroviral therapy (ART). Viral hyper-excretion relative to blood is a hallmark of reservoirs. To determine whether hyper-excretion can occur in the oral cavity, we compared viral loads in blood plasma and saliva of 67 adults. Salivary viral hyper-excretion was defined as a four-fold or higher viral load in saliva than in plasma. HIV-1 RNA was detected in 79% of plasma samples, in 44% of unfiltered saliva samples, in 16% of filtered saliva samples, and in 59% of saliva-derived cell pellets. Compared with non-hyper-excretors (n = 62), hyper-excretors (n = 5) had elevated levels of viral RNA in unfiltered saliva and saliva-derived cells, HIV-associated periodontal disease, gingival inflammation, and no combination ART. Morphological characterization of cell pellets identified lymphocytes as a likely HIV-1 source. These collective findings are consistent with an oral HIV-1 reservoir in selected individuals.
Barr CE, Qureshi MN, Qiu Z., Kaim J., Zhang W. (1996). Oral HIV-1 recovery in the presence of periodontal disease. Oral Dis2 :198-201.
2.
Centers for Disease Control (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Wkly Rep41:1-19.
3.
Cohen MS, Hoffman IF, Royce RA, Kazembe P., Dyer JR, Daly CC, et al. (1997). Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet349:1868-1873.
4.
EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Center on Oral Manifestations of the Immunodeficiency Virus (1993). Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med22:289-291.
5.
Edgar WM (1992). Saliva: its secretion, composition and functions . Br Dent J172:305-312.
6.
Eron JJ, Vemazza PL, Johnston DM, Seillier-Moiseiwitsch F., Alcorn TM, Fiscus SA, et al. (1998). Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS12:F181-F189.
7.
Eron JJ Jr, Smeaton LM, Fiscus SA, Gulick RM, Currier JS, Lennox JL, et al. (2000). The effects of protease inhibitor therapy on human immunodeficiency virus type-1 levels in semen (AIDS Clinical Trials Group Protocol 850). J Infect Dis181:1622-1628.
8.
Fatkenheuer G., Theisen A., Rockstroh J., Grabow T., Wicke C., Becker K., et al. (1997). Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS11 :F113-F116.
9.
Faust RA, Henry K., Dailey P., Melroe H., Sullivan C., Erice A., et al. (1996). Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers. Otolaryngol Head Neck Surg114:593-598.
10.
Frankel SS, Wenig BM, Burke AP, Mannan P., Thompson Ldr, Abbondanzo SL, et al. (1996). Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science272:115-117.
11.
Hart CE, Lennox JL, Pratt-Palmore M., Wright TC, Schinazi RF, Evans-Strickfaden T., et al. (1999). Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis179:871-882.
12.
Ho DD, Neumann AU, Perelson AS, Chen W., Leonard JM, Markowitz M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature373:123-126.
13.
Liuzzi G., Chirianni A., Clementi M., Bagnarelli P., Valenza A., Tullio Cataldo P., et al. (1996). Analysis of HIV-1 load in plasma, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS10:F51-F56.
14.
Loe H., Silness J. (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand21 :533-551.
15.
May RM (1996). The art and science of cytopathology. Chicago, IL: ASCP Press.
16.
Odden K., Schenck K., Hurlen B. (1995). High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Pathol Med24:413-419.
17.
Offenbacher S. (1996). Periodontal diseases: pathogenesis. Ann Periodontol1:821-878.
18.
Overbaugh J., Anderson RJ, Ndinya-Achola JO, Kreiss JK (1996). Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res Hum Retroviruses12:107-115.
19.
Padian N., Glass S. (1997). Transmission of HIV possibly associated with exposure of mucous membrane to contaminated blood. Morbid Mortal Wkly Rep46:620-621.
20.
Rothenberg RB, Scarlett M., del Rio C., Reznik D., O'Daniels C. (1998). Oral transmission of HIV. AIDS12:2095-2105.
21.
Saag MS, Holodniy M., Kuritzkes DR, O'Brien WA, Coombs R., Poscher ME, et al. (1996). HIV viral load markers in clinical practice . Nature Med2:625-629.
22.
Schrager LK, D'Souza MP (1998). Cellular and anatomic reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAm Med Assoc280:67-71.
23.
Shugars DC, Wahl SM ( 1998). The role of the oral environment in HIV-1 transmission . JAm Dent Assoc129:851-858.
24.
Shugars DC, Slade GD, Patton LL, Fiscus SA (2000). Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod89:432-440.
25.
Suzuki T., Tai H., Yoshie H., Jeannel D., Fournier S., Dupont B., et al. (1997). Characterization of HIV-related periodontitis in AIDS patients: HIV-infected macrophage exudate in gingival crevicular fluid as a hallmark of distinctive etiology. Clin Exp Immunol108:254-259.
26.
Tachet A., Dulioust E., Salmon D., De Almeida M., Rivalland S., Finkielsztejn L., et al. (1999). Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS13 :823-831.
27.
Uccini S., Riva E., Antonelli G., D'Offizi G., Prozzo A., et al. (1999). The benign cystic lymphoepithelial lesion of the parotid gland is a viral reservoir in HIV type 1-infected patients . AIDS Res Hum Retroviruses15:1339-1344.
28.
Uvin SC, Anderson D., Parekh B. (1997). Human immunodeficiency virus-1 shedding in the genital tract of a female long-term nonprogressor without detectable plasma human immunodeficiency virus ribonucleic acid. Am J Obstet Gynecol177:490-491.
29.
US Department of Health and Human Services, National Institutes of Health, Oral health surveys of the National Institute of Dental Research (1991). Diagnostic criteria and procedures . NIH publication #91-2870, pp. 1-99.
